SEC Filings
Olema Pharmaceuticals Becomes Olema Oncology — Shareholders Keep The OLMA Ticker And Valid Certificates
The cancer-drug developer also moved its executive offices to South San Francisco as it prepares for possible palazestrant commercialization.